GoodRx reported that its revenue missed analyst estimates by 1.3% in August 2025.
1 report, 1 independent
Updated Aug 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GoodRx reported that its revenue missed analyst estimates by 1.3% in August 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.GoodRx Holdings Second Quarter 2025 Earnings: Misses Expectations Revenue: US$203.1m (up 1.2% from 2Q 2024). Net income: US$12.8m (up 92% from 2Q 2024). Profit margin: 6.3% (up from 3.3% in 2Q 2024).